We describe initial steps for interrogating whole-genome sequence data to characterize the genetic architecture of a complex trait, levels of high-density lipoprotein cholesterol (HDL-C). We report whole-genome sequencing and analysis of 962 individuals from the Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) studies. From this analysis, we estimate that common variation contributes more to heritability of HDL-C levels than rare variation, and screening for mendelian variants for dyslipidemia identified individuals with extreme HDL-C levels. Whole-genome sequencing analyses highlight the value of regulatory and non-protein-coding regions of the genome in addition to protein-coding regions.
l e t t e r s
We describe initial steps for interrogating whole-genome sequence data to characterize the genetic architecture of a complex trait, levels of high-density lipoprotein cholesterol (HDL-C). We report whole-genome sequencing and analysis of 962 individuals from the Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) studies. From this analysis, we estimate that common variation contributes more to heritability of HDL-C levels than rare variation, and screening for mendelian variants for dyslipidemia identified individuals with extreme HDL-C levels. Whole-genome sequencing analyses highlight the value of regulatory and non-protein-coding regions of the genome in addition to protein-coding regions.
Before now, whole-genome sequencing-based studies have been used to identify mutations underlying rare mendelian disorders 1, 2 but not to explore the genetic architecture of common complex traits. This study evaluates the use of whole-genome sequence data in a population-based sample of well-phenotyped individuals to assess three major genotype-phenotype relationships in an unbiased, hypothesis-free and coordinated approach in order (i) to estimate the relative contribution of common and rare variation to the heritability of a quantitative trait relevant to health and disease; (ii) to identify individuals who carry variants causing mendelian disease and analyze the effects of these variants on phenotypes in apparently asymptomatic individuals; and (iii) to determine the relative value of regulatory and non-protein-coding regions of the genome compared with the protein-coding portions.
We sequenced 962 individuals ( Supplementary Table 1 ) at 6-fold average depth. We identified over 25 million genetic variants and annotated this variation across regions and functional domains (Supplementary Note). The largest proportion of observed variants was intergenic (58%); an additional 6% of variants were in annotated functional domains, with noncoding RNAs housing the largest fraction ( Supplementary Table 2 ). Of the 252,764 exonic variants identified, 154,133 (61%) were either nonsynonymous, stop-gain or stop-loss changes. Common variation (minor allele frequency (MAF) > 1%) represented 35.7% of the ~25 million variants identified (Supplementary Table 3 ). The proportion of rare variation (MAF < 1%) was 70.8% in exonic regions (UTRs and coding sequences), 65.3% in intronic regions and 64.4% in intergenic regions.
To illustrate several analytic approaches for whole-genome sequencing analyses of a complex trait, we selected HDL-C levels, a health-related phenotype that is widely and accurately measured. High HDL-C levels are associated with reduced risk of cardiovascular disease 3 , but, so far, a role for HDL-raising therapies in lowering disease risk has not been established. On the basis of correlation in measurements among twins and other relative pairs, the estimated heritability of HDL-C levels is 47-76% ( Supplementary Table 4 ). We extended the linear mixed models method of Yang et al. 4, 5 to estimate the contributions of variants within different MAF bins to heritability for this trait. For each MAF bin used for estimating the genetic relationship matrix (GRM) in the linear mixed model, we adopted an adjustment threshold, θ, specifically matching that MAF bin, to account for the distribution of undetected causal variants. We validated our method by computer simulation (details of the estimation method and simulation validation can be found in the Supplementary Note). Our simulations showed that, in general, the estimated genetic variances matched the true values for both high-coverage and low-coverage scenarios ( Supplementary  Fig. 2 ) and for all three minor allele count (MAC) bins (rare, MAC ≤ 0.01; low frequency, 0.01 < MAC ≤ 0.05; common, MAC > 0.05), as shown in Supplementary Figure 3 . From the whole-genome sequence data reported here, we estimate that common variants (MAF > 1%) explain 61.8% (standard error of 14.2) of the variance Whole-genome sequence-based analysis of high-density lipoprotein cholesterol 9 0 0 VOLUME 45 | NUMBER 8 | AUGUST 2013 Nature GeNetics l e t t e r s in HDL-C levels and that rare variants (MAF < 1%) explain an additional 7.8% (standard error of 9.8) of the variance ( Supplementary  Table 5 ). In the estimate of variance explained by each chromosome (Supplementary Fig. 3 ), there was a positive correlation with both the chromosome length (r = 0.37) and the total number of common variants observed on each chromosome (r = 0.40).
We detected 1,243 variants previously reported to cause mendelian disorders in the Human Gene Mutation Database (HGMD; disease-causing mutation, DM) 6 . Altered HDL-C levels were a published characteristic for ten of these variants in four genes (Online Mendelian Inheritance in Man (OMIM), see URLs; Supplementary  Table 6 ), each of which was validated by an independent genotyping technology. For each of the ten variants, a Wilcoxon rank-sum test was conducted, and none of these variants was significant on the basis of a Bonferroni-adjusted significance threshold of P = 0.005. Three examples representing diverse clinical presentations among individuals carrying known pathological variants are shown in Figure 1 . One individual is heterozygous for a variant in ABCA1 (encoding ATP-binding cassette, subfamily A member 1) that was first reported in a large kindred with Tangier disease 7 . This individual had HDL-C levels that fell in the low extreme of the distribution (8.1 percentile; Wilcoxon rank-sum P value = 0.07). Variable penetrance was shown in two individuals with an ABCA1 intronic variant first reported in a kindred with hypoalphalipoproteinemia and premature coronary disease 8 . One of the individuals had very low HDL-C levels (4.6 percentile), whereas the other had less severely reduced levels (31.1 percentile; Wilcoxon rank-sum P value for both individuals = 0.06). Two individuals were heterozygous for the same mutation in APOA1 (encoding apolipoprotein A-I) that was first reported in an individual with severe hypoalphalipoproteinemia 9 . Both presented with low HDL-C levels (10.1 and 6.2 percentiles; Wilcoxon rank-sum P value for both individuals = 0.02).
Our approach to evaluating phenotype-whole-genome sequence associations allows for a global survey of the entire genomic landscape, complemented by an annotation-based assessment of the genome. Results for two statistically significant regions of the genome are shown that, respectively, include the annotated regulatory unit (sequence kernel association test (SKAT) rare variant test P = 1.09 × 10 −7 ; Fig. 2a ) and sliding window (T1 rare variant test P = 2.69 × 0 −8 ; Fig. 2b ) with the strongest association. Results for the entire genome are available along with a tool, Lachesis, to view any region of interest (see URLs). Three types of results are shown: single-SNP analyses, a sliding window aggregating the contribution of rare variants and burden tests for a priori annotated regions. The numbers of tests that were conducted for each type of analysis are summarized in Supplementary Table 7 .
As an illustration of these data, a snapshot of the genomic contribution to interindividual variation in HDL-C levels is shown for a region on chromosome 16 encompassing the CETP gene (encoding cholesteryl ester transfer protein) ( Fig. 2a) . Whole-genome sequence showed the contribution of variation beyond that previously identified from genome-wide association studies (GWAS) for HDL-C levels (for example, index variant rs3764261 located 5′ of CETP 10 ). Previous work indicates that CETP is likely subject to regulatory variation that affects both transcription initiation and interindividual splicing of 75,830,000 75,840,000 75,850,000 75,860,000 75,870,000 75,880,000 75,890,000 75,900,000 PARM1 Figure 2 Survey of the genomic landscape using Lachesis. Global assessment of the genome is accomplished by interrogating common variation in a comprehensive GWAS (super-GWAS). Additionally, a sliding window of physical distance (4 kb) was used to evaluate the aggregate contribution of rare (T1) and all (SKAT) variation across the entire genome. Annotation-based analyses at the gene level contrast the contribution to phenotypic variation from protein-coding variation (exon only) and the addition of gene-based regulatory regions (exon + regulatory). Noncoding regions, such as microRNAs and long intergenic noncoding RNAs (lincRNAs), and annotated regulatory regions (ORegAnno 15 ) throughout the genome were also evaluated for phenotypic association with the aggregate contributions of rare and common variation in these regulatory domains. Other annotations can be added to these analyses as they emerge. (a,b) The genomic contribution to interindividual variation in HDL-C levels is shown for regions on chromosome 16 (a) and chromosome 4 (b). l e t t e r s exon 9 (ref. 11). Whole-genome sequence showed the full array of common variation contributing to HDL-C levels in the 5′ region of CETP and highlighted a CEBPβ transcription factor binding site (OREG0001947). This domain at position 56,995,236 coincides with rs1800775, the variant at −629 relative to the transcriptional start site previously suggested as functional via allelic reporter gene and gel shift assays 12 . A second set of regulatory elements (OREG0023819) was found to reside in intron 2 and spans a region from 56,998,238 to 56,998,689, encompassing a novel variant at 56,998,522 bp. The functional relevance of the intron 2 regions is robustly supported by Encyclopedia of DNA Elements (ENCODE) data, including histone markers, DNase I hypersensitivity sites and the results of chromatin immunoprecipitation and sequencing (ChIP-seq) experiments for transcription factors.
A feature of the ability to scan the genome using the sliding-window approach is the capability of agnostically identifying potentially informative genomic regions in the absence of previous biological information. A region on chromosome 4 near PARM1 (encoding prostate androgen-regulated mucin-like protein 1 precursor; Fig. 2b ) was identified by a sliding-window test that counts the number of alternate alleles across variants with MAF of <1% (T1) and a SKAT that considers the contribution of all variation within the window. The associated signals we identified were near a transcript of uncertain coding potential (TCONS_00008503) and markers of histone and transcription factor activity. The presumed promoters of PARM1 and TCONS_00008503 appear to lie in head-to-head formation, indicating potential coregulation.
The results presented here document the tractable nature of wholegenome sequence analysis for characterizing the genetic architecture of common complex phenotypes in humans. We have opted to control costs while still obtaining a large sample size by targeting a depth of coverage that yields a high probability of identifying variants contributing to the genetic architecture of human disease. A sample size of 1,000 individuals with 6-fold average coverage yields a high probability (>98%) of detecting variants down to a frequency of 0.5% (ref. 13) . We have taken a multifaceted analytic approach that is meant to establish a starting point for future investigation of other phenotypes, larger sample sizes and updated models of genome function. By using whole-genome sequencing instead of genome-wide association or candidate gene studies, we are able to obtain an unbiased glimpse of the relative contributions of rare and common variation to the heritability of a model trait. The results indicate that the majority (that is, 61.8%) of the heritability of HDL-C levels can be attributable to common variation. Given the results of GWAS and targeted resequencing, these common variants likely represent true polygenic variations with small effects, which are of limited diagnostic use but may be important in identifying the biological pathways involved. The results show that, from the entire distribution of randomly sampled individuals, a portion of them in the tails of the phenotype distribution have rare variants with large effects 14 , and some of these rare variants have previously been identified in mendelian conditions. The approach and the data also demonstrate the value added of whole-genome sequencing beyond that afforded by whole-exome sequencing. Clearly, there are emerging challenges and opportunities for annotating and integrating the functional and disease-associated regions in the human genome.
URLs. OMIM, http://www.omim.org/; Lachesis, http://www. chargeconsortium.com/main/lachesis; SNPTools, http://www.hgsc. bcm.tmc.edu/content/SNPTools; ORegAnno (accessed March 2012), http://www.oreganno.org/.
MEtHoDs
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
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oNLINE MEtHoDs
Description of whole-genome sequencing and calling. Library construction processes for the Illumina pipeline are fully automated at the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC). This automated pipeline uses the Biomek NX Span 8 liquid handler in tandem with the Biomek FX or NX platform. Established automated steps in the library construction process include DNA aliquotting, end repair, 5′ adenylation, adaptor ligation, library amplification and sample pooling using the Biomek Span 8 platform. Solid-Phase Reversible Immobilization (SPRI) bead purification associated with end repair, nick translation and PCR amplification steps are all performed on the Biomek FX and NX platforms. All processes in library construction are fully Laboratory Information Management System (LIMS) integrated for tracking sample identities on reaction plates to prevent sample swaps. LIMS interfacing allows downstream sequencing data to be deconvoluted, with reads being assigned to the appropriate barcodes, libraries and samples during analysis. So far, over 15,000 libraries have been completed using these automated methods for capture and whole-genome sequence application, with up to 96 sample barcodes now employed for multiplexing. For this project, Illumina paired-end libraries were barcoded with standard Illumina multiplex adaptors and pooled for sequencing in sets of three samples to generate an average of 6-fold sequence coverage per sample.
Methods for whole-genome sequencing followed standard Illumina paired-end library protocols with minor modifications. DNA concentration was determined using PicoGreen assays, and DNA integrity was determined using Agilent Bioanalyzer traces and agarose gels. Libraries were constructed using 1 µg of genomic DNA in a 100-µl volume that was sheared into fragments of approximately 300 bp in length using a Covaris plate with the E210 system (Covaris). The instrument was set for a 10% duty cycle and intensity of 4,200 cycles per burst for 120 s. Fragment size was checked using a 2.2% Flash Gel DNA Cassette (Lonza, 57023). Fragmented DNA was end repaired in a 90-µl total reaction volume containing sheared DNA, 9 µl of 10× buffer, 5 µl of END Repair Enzyme Mix and water (NEBNext End-Repair Module, E6050L), and samples were incubated at 20 °C for 30 min. A-tailing was performed in a total reaction volume of 60 µl containing end-repaired DNA, 6 µl of 10× buffer, 3 µl of Klenow fragment (NEBNext dA-Tailing Module, E6053L) and water, and samples were incubated at 37 °C for 30 min. Ligation with Illumina multiplex adaptors (NEBNext Quick Ligation Module, E6056L) was performed in a total reaction volume of 90 µl containing 18 µl of 5× buffer, 5 µl of ligase, 0.5 µl of 100 µM adaptor and water, and samples were incubated at room temperature for 30 min. After ligation, PCR was performed with Illumina Paired-End 1.0 and modified barcode primers in 170-µl reactions containing 85 µl of 2× Phusion High-Fidelity PCR master mix, adaptor-ligated DNA, 1.75 µl of 50 µM of each primer and water. Standard thermocycling for PCR involved 5 min at 95 °C for the initial denaturation followed by 6-10 cycles of 15 s at 95 °C, 15 s at 60 °C and 30 s at 72 °C, and a final extension for 5 min at 72 °C. Agencourt XP Beads (Beckman Coulter Genomics, A63882) were used to purify DNA after each enzymatic reaction. After bead purification, PCR products were quantified and their size distribution examined using the Caliper GX 1K/12K/High-Sensitivity Assay Labchip (760517). The mean depth of coverage was 6-fold, with minimum coverage of 4.0-fold and maximum coverage of 17.4-fold. Sixfold average coverage for each individual was accomplished through barcoding of each sample during library generation followed by a 3-plex sample pooling strategy instrument loading. Each pool was then loaded into two HiSeq lanes, and data for individual samples were merged to generate 6-fold coverage (~24 Gb of sequence per sample). Mapping was performed using the Burrows-Wheeler Aligner (BWA) 16 with the GRCh37 (hg19) reference genome.
The SNPTools (see URLs) pipeline was developed at BCM-HGSC for singlenucleotide variant (SNV) calling. SNPTools is an integrative pipeline that can achieve high quality for (i) variant site discovery, (ii) genotype likelihood estimation and (iii) genotype and/or haplotype inference via imputation. The SNPTools algorithm includes a variance ratio statistic for initial site discoveries. This statistic compares the difference in variation contributed from the variant read coverage (in the case that the variant is a true positive) and the variation that would be due to sequencing and mapping errors (in the case that the variant is a false positive). The larger the variance ratio statistic, the more likely it is that the site is a true polymorphic site. In the CHARGE whole-genome sequence data set, we applied the default cutoff of 1.5 for the variance ratio statistic. SNPTools next estimates genotype likelihoods by clustering all candidate sites within each particular BAM file to overcome data heterogeneity using a mixture model. This step is named the BAM-specific Binomial Mixture Model (BBMM). BBMM normalizes the heterogeneity within each sample BAM by estimating BAM-and sample-specific parameters. It takes into consideration all the variant sites identified from the sample collection (~25 million sites in the final sample of 962 individuals) and clusters across sites in one particular BAM to estimate the genotype likelihoods. By clustering the scale read depth across millions of sites, this approach substantially reduces the variance and improves the accuracy of genotype likelihood estimation. Genotype likelihood values are used by the imputation engine to refine the individual genotypes and to phase haplotypes.
Whole-genome sequence quality control and quality assurance. Quality control and quality assurance checks were performed on the whole-genome sequence using the VCF file with imputed genotypes from SNPTools. These procedures were completed for all individuals from all cohorts. Pairwise identity by state (IBS) was evaluated by PLINK 17 to identify pairs of individuals with greater than expected allele sharing. Individuals with excess IBS were consistent across all chromosomes considered and segregated from the rest of the population. A cutoff of 0.94 pairwise IBS was used to identify pairs of individuals showing greater than expected allele sharing. This threshold identified 25 pairs of individuals from FHS with known familial relationships (9 parent-offspring pairs, 4 sibling pairs, 7 avuncular pairs, 1 first-cousin pair and 4 unrelated pairs). Two individuals from FHS were represented in two separate pairs. From each set of individuals, the sample with the lower whole-genome sequence coverage was removed from further analysis. An additional three pairs were identified that comprised a set of two individuals from ARIC and two sets of ARIC-CHS pairs. From each pair of individuals, the sample with the lower whole-genome sequence coverage was removed from further analysis. On the basis of the evaluation of IBS, a total of 26 individuals (23 from FHS, 2 from ARIC and 1 from CHS) were removed.
Principal-components analysis (PCA) was used to identify possible population substructure and sample abnormalities. The set of variants for PCA was restricted to variants with MAF of >5% and linkage disequilibrium between variants of r 2 < 0.30. Consistently, two individuals from FHS were identified as outliers by principal component 1 and were removed from further analyses. The two FHS individuals identified by PCA were also outliers for singleton counts and total number of heterozygous counts and were removed from analyses. Higher-order principal components showed minor levels of population structure. After sample-level quality control, a total of 962 individuals (404 from ARIC, 237 from CHS and 321 from FHS) were available for the genotype-phenotype analyses reported here.
Variant-level quality assurance was achieved by a comparison of whole-genome sequences with whole-exome sequences available for 886 of the 962 individuals. Comparing variants identified in 886 overlapping samples having high-coverage whole-exome capture sequence (average coverage of 115-fold per sample), the overall genotype concordance rate was higher than 99% across the spectrum of MAF. The rediscovery probability in these data for sites with MAF of >0.5% and a sample size of ≥500 was greater than 95%. Even at MAFs of 0.2-0.5%, the rediscovery probability remained as high as 80%, and was ~45% at a MAF of 0.1%. The rate improves with increased sample size, and, therefore, our results provide a lower bound for the rediscovery rate for the 962 samples. The concordance rate between the whole-genome sequence and GWAS array data was 99%. When compared with the deep sequencing exome data from the same set of individuals, we estimated that SNPTools had effectively discovered more than 95% of the variants with MAF of >0.5%, whereas the estimated discovery power for singletons and doubletons was limited to 45%.
Identification of mendelian variation.
To identify known mendelian variants influencing HDL-C levels, we used the strengths of HGMD and the OMIM catalog. This approach had two stages: the first stage identified all mendelian variants in our cohort, and the second applied a clinically derived gene-based filter to the set of annotated sequences. npg A complete list of HGMD (version 2011.4) single-nucleotide substitutions was annotated using ANNOVAR 18 . Of the 25,124,797 SNVs observed in the 962 individuals, a total of 3,920 SNVs matched HGMD, of which 1,688 were designated as disease-causing (DM) alleles. We then removed variants with only association or dubious evidence for pathogenicity, as indicated in the HGMD disease field, reducing the observed set of HGMD-DM variants to 1,243.
Independently, we queried OMIM for HDL-C-related terms (for example, 'HDL' , 'hyperalphalipoprotein' and 'hypoalphalipoprotein') to identify genes causing mendelian disorders influencing HDL-C levels. The intersection of this gene filter with the set of HGMD-DM variants identified 14 variants in our cohort. After reviewing the OMIM clinical descriptions of the corresponding disorders, we removed four variants not directly related to HDL-C levels. The carriers of the ten HGMD-DM variants related to HDL-C levels and their percentiles within the HDL-C sample distribution adjusted for age, sex, body mass index (BMI) and cohort field center are shown in Supplementary Table 6 . All 10 variants were technically validated in the 21 individuals who carried them by either capture-based exome sequencing, Sequenom genotyping or both.
Super-GWAS.
All SNVs with MAF of >1% were evaluated for association with HDL-C levels, assuming an additive genetic model. Age, sex, BMI and study center were included as covariates. A total of 8,969,552 SNVs were tested. Manhattan and quantile-quantile plots for the super-GWAS for HDL-C levels are shown in Supplementary Figures 4 and 5 , respectively.
Genome scanning by sliding window. The sliding window across the genome considered the aggregate contribution of variants to the trait. The composition of the 1.33 million windows, covering 2.7 billion autosomal base pairs, is shown in Supplementary Figure 6 . The median numbers of common (MAF > 1%) and rare (MAF < 1%) SNVs in a window were 12 and 28, respectively (interquartile ranges of 8-17 and 19-28). Sliding windows were 4 kb in length and began at position 0 bp for each chromosome; the skip length was 2 kb.
Primary considerations for the choice of tests were (i) representing a test with an ability to be statistically powered for the scenario where all variants in the defined window have effects in the same direction as well as a test that allows for omnidirectional effects of the variants, (ii) ease of calculation and implementation, including computational speed, and (iii) application to quantitative and qualitative outcomes. The T1 test generates a statistic for each person that counts the number of variant alleles across SNVs with MAF of <1%. The summary statistic for each person is used in the linear regression model, and a Wald test was used to assess significance. SKAT 19 performs a score test for the model that includes all variants within the window. This allows for heterogeneous effect of the variants within a window but has lower power to detect homogeneous effects relative to T1. For linear regression, the score test comes from the model
where x ik is the kth covariate for subject i (i = 1, …, n), G ij is the jth genotype for subject i, j = 1 to p, and α 0 , α k and β j are regression parameters. SKAT is a weighted sum of the score tests for each individual variant, where the weights are specified by the user. For testing the null hypothesis H 0 of β = 0, SKAT takes a simple form. Let G ij be the genotype of the jth variant for the ith person. For a given set of weights, w j for each variant j = 1 to p, the score test can be expressed as and ˆm m i0 is the predicted value of y i from the model when there are no genotypes in the model.
We chose w i = f(MAF(G i )), where f(x) is the density of a β(1,25) distribution, which gives more testing weight to rare variants relative to common variants.
Quantile-quantile plots for the sliding-window evaluation of the aggregate contribution of variants to HDL-C levels are shown for T1 ( Supplementary  Fig. 7a) and SKAT (Supplementary Fig. 7b ).
Sources of regulatory and noncoding annotation. All annotations were obtained with positional mapping to human genome build GRCh37 (hg19). The Open REGulatory ANNOtation database (ORegAnno) provided a resource of 23,119 regulatory assays mapped to the human genome, with corresponding literature citations 20 . Human lincRNAs (n = 8,195) were taken from a catalog developed on the basis of RNA sequencing of 24 human tissues and cell types 21 and subject to additional padding as with RefSeq genes. Regulatory and noncoding annotation sources were evaluated with SKAT and T1 (Supplementary Figs. 8 and 9 ) on the basis of variants from whole-genome sequencing that intersected with the individual annotation entries.
Like the sliding window across the genome, annotation-based analyses considered the aggregate contribution of variants within a defined region. Gene-based methods contrasted the contribution to phenotypic variation from protein-coding variation and the addition of gene-based regulatory regions. Gene regions were annotated using the RefSeq database 22 , including definition of exon boundaries. A total of 216,362 exonic regions were captured across the genome in a total of 23,357 genes. The gene-based regulatory regions were identified using RefSeq as follows: 500 bp upstream (5′) from exon 1 and downstream (3′) from the last exon, the first 500 bp of intron 1 and 10 bp into each intron for the identification of splice sites. The aggregate contribution of variants to HDL-C levels was determined within exon-only ( Supplementary  Fig. 10 ) and gene-based ( Supplementary Fig. 11 ) regulatory regions using T1 and SKAT.
Significance thresholds and false positive control. Correlation between tests will influence the joint behavior of P values. However, we note that a significance threshold controls the expected number of false positives regardless of the correlation between tests 23 . For instance, the sliding-window analysis comprised 2 tests on each of 1.3 million windows for a total of 2.6 million tests. If one were to use a significance threshold of P = 4.0 × 10 −7 , the number of expected false positives among all sliding-window tests would be less than 1.05. We have refrained from specifying precise significance thresholds, as acceptable false positive rates will differ depending on the nature of follow-up studies. However, we recommend using different significance thresholds for each analysis to account for the differing number of tests used. In this way, the results from the gene-based tests are not hidden by the large number of super-GWAS tests. The false positive rate across the study is then less than the sum of the expected number of false positives from each analysis. The numbers of tests that were conducted for each type of analysis are summarized in Supplementary Table 7 .
